Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cross Country Healthcare (CCRN) Shares Outstanding (Diluted Average) (2016 - 2025)

Historic Shares Outstanding (Diluted Average) for Cross Country Healthcare (CCRN) over the last 17 years, with Q3 2025 value amounting to $32.5 million.

  • Cross Country Healthcare's Shares Outstanding (Diluted Average) fell 356.97% to $32.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $32.5 million, marking a year-over-year decrease of 356.97%. This contributed to the annual value of $33.4 million for FY2024, which is 591.1% down from last year.
  • Cross Country Healthcare's Shares Outstanding (Diluted Average) amounted to $32.5 million in Q3 2025, which was down 356.97% from $32.5 million recorded in Q2 2025.
  • In the past 5 years, Cross Country Healthcare's Shares Outstanding (Diluted Average) registered a high of $38.0 million during Q1 2022, and its lowest value of $32.3 million during Q1 2025.
  • Over the past 5 years, Cross Country Healthcare's median Shares Outstanding (Diluted Average) value was $36.0 million (recorded in 2023), while the average stood at $35.6 million.
  • In the last 5 years, Cross Country Healthcare's Shares Outstanding (Diluted Average) surged by 388.66% in 2021 and then tumbled by 669.13% in 2025.
  • Cross Country Healthcare's Shares Outstanding (Diluted Average) (Quarter) stood at $37.4 million in 2021, then grew by 0.39% to $37.5 million in 2022, then dropped by 5.49% to $35.5 million in 2023, then decreased by 5.91% to $33.4 million in 2024, then dropped by 2.56% to $32.5 million in 2025.
  • Its Shares Outstanding (Diluted Average) was $32.5 million in Q3 2025, compared to $32.5 million in Q2 2025 and $32.3 million in Q1 2025.